Resources
7 Results (showing 1 - 7)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 9/18/2020 (updated 3/29/2024)
We have included information that will be relevant
to the broad range of HRSA RCORP-Planning grantees.
We encourage you to work through this packet section by
section, keeping in mind the timeline for final submission of
core grant deliverables.
Posted 9/18/2020 (updated 3/29/2024)
This is the template for the PIII Community Needs Assessment and Gap Analysis deliverable.
Posted 10/28/2020 (updated 4/3/2024)
These sample Needs Assessments have been created by RCORP Planning grantees. Please note, these samples are from Planning II grantees and the required elements for the Planning III cohort Needs Assessments have changed. Please refer to the list of required elements for Planning III grantees in your RCORP Planning III Orientation Packet.
Posted 11/11/2021 (updated 4/3/2024)
Joined this panel of former RCORP-Planning grantees as they shared their lessons learned and how they hit the ground running as they completed Planning and embarked on Implementation. Heard from panelists who received Implementation funding as well as those who were able to move forward without dedicated Implementation funding.
Posted 12/23/2020 (updated 4/4/2024)
This technical package provides evidence of the effectiveness of strategies and approaches for supporting successful planning, design, implementation, and sustainability of syringe services programs (SSPs). It provides a broad framework for new and existing SSPs to ensure needs-based service delivery, reduce harms related to injection drug use, and link participants to services that support their health and wellness.
Posted 4/5/2024
This study assessed the associations between insurance status and 6-month retention of patients with opioid use disorder on telehealth platforms. Patients whose insurance paid for their care were most likely to still be receiving buprenorphine 6 months after starting treatment. Uninsured patients who paid cash were more likely to be in treatment at 6 months than people with insurance that did not cover their care. Findings showed an association between in-network insurance benefits and retention, which may affect the opioid crisis.
Posted 5/17/2021 (updated 4/10/2024)
New medications for office-based treatment of opioid
addiction are comparable in efficacy to other chronic
conditions such as diabetes, asthma, and hypertension
when combined with other interventions and as part of a
comprehensive care plan. They are safe, highly effective,
can be prescribed and/or administered at the Community
Health Center, with a sustainable business plan.